Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2021

Jun 17, 2021

33625_dirs_2021-06-17_4e03a4c8-feca-4a79-87a1-f49cbb22d81d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-06-15

Reporting Person: Huggenberger Raymond (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-15 Common Stock M 4000 $38.54 Acquired 27670 Direct
2021-06-15 Common Stock S 4000 $63.8656 Disposed 23670 Direct
2021-06-15 Common Stock S 3087 $63.7349 Disposed 20583 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-15 Stock Option (Right to Buy) $38.54 M 4000 Disposed 2022-05-15 Common Stock (4000) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

F2: Represents the weighted average share price of an aggregate total of 4,000 shares sold in the price range of $63.28 to $64.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 3,087 shares sold in the price range of $63.11 to $64.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: The previously filed Form 4 on January 16, 2019 listed an incorrect number.